1. 1950 Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. (September 2015) Authors: Gamucci, T.; Mentuccia, L.; Vici, P.; Iezzi, L.; Sperduti, I.; Astone, A.; Marchetti, P.; Pizzuti, L.; Michelotti, A.; Sini, V.; Cassano, A.; Ciancola, F.; Quadrini, S.; Moscetti, L.; Landucci, E.; Sergi, D.; Magnolfi, E.; Natoli, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1849 Italian observational study of Eribulin Mesylate in patients with advanced breast cancer: ESEMPiO study. (September 2015) Authors: Barni, S.; Fontanella, C.; Del Mastro, L.; Livraghi, L.; Morritti, M.; Pizzuti, L.; Michelotti, A.; Lutrino, E.S.; Ciccarese, M.; Musolino, A.; Quercia, S.; Garrone, O.; Pellegrino, A.; Pistelli, M.; Martella, F.; Iezzi, L.; Mentuccia, L.; Latorre, A.; D'Onofrio, L.; Porcu, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience. (October 2016) Authors: Moscetti, L.; Vici, P.; Gamucci, T.; Natoli, C.; Cortesi, E.; Marchetti, P.; Santini, D.; Giuliani, R.; Sperduti, I.; Mauri, M.; Pizzuti, L.; Mancini, M.L.; Fabbri, M.A.; Magri, V.; Iezzi, L.; Sini, V.; D'Onofrio, L.; Mentuccia, L.; Vaccaro, A.; Ramponi, S. Journal: Breast Issue: Volume 29(2016) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗